Value of biomarkers in epithelial-mesenchymal transition models of liver cancer under different interventions: a meta-analysis

Future Oncol. 2022 Nov;18(36):4031-4045. doi: 10.2217/fon-2022-0344. Epub 2023 Jan 9.

Abstract

Aim: A meta-analysis was conducted to evaluate the effectiveness of crucial biomarkers in HepG2 cells during epithelial-mesenchymal transformation induced by multiple interventions. Methods: PubMed, Web of Science, Embase, China National Knowledge Infrastructure, Chinese Biomedical Literature Database, Wan Fang Data and VIP databases were systematically searched from inception to 14 June 2020, by two independent reviewers. Results: A total of 58 studies were included in the meta-analysis. E-cadherin, N-cadherin and vimentin performed well under medicinal interventions. E-cadherin worked well under genetic interventions. E-cadherin and N-cadherin also performed significantly well under tumor microenvironment interventions. Under ncRNA interventions, the expression of E-cadherin significantly changed. Conclusion: Different sets of biomarkers should be selected under various interventions based on their performance.

Keywords: EMT; HepG2; biomarkers; liver cancer; meta-analysis.

Publication types

  • Systematic Review
  • Meta-Analysis
  • Review

MeSH terms

  • Biomarkers
  • Biomarkers, Tumor / metabolism
  • Cadherins / genetics
  • Cadherins / metabolism
  • China
  • Epithelial-Mesenchymal Transition* / genetics
  • Humans
  • Liver Neoplasms* / genetics
  • Liver Neoplasms* / therapy
  • Tumor Microenvironment

Substances

  • Biomarkers
  • Cadherins
  • Biomarkers, Tumor